Virax Biolabs Group Ltd. (VRAX)
Market Closed
18 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 17
+0
+2.3669%
$
798.92K Market Cap
- P/E Ratio
- Div Yield
1.03M Volume
0 Eps
$ 0.17
Previous Close 
Want to track VRAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Virax Biolabs Group Ltd. (VRAX) Statistics
Valuation metrics
Market Cap 798.92K
Enterprise value -2.06M
Trailing P/E (ttm) -0.15
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 251.56
Price/Book (mrq) 0.16
Enterprise Value/Revenue -688.65
Enterprise Value/EBITDA 0.37
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.2M
Average volume (90 days) 36.74M
Price summary
52-Week low 0.1
52-Week high 1.14
Beta -
50-Day moving average 0.19
200-Day moving average 0.25
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 18 Dec 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1,890.02%
Operating margin -1,965.67%
Operational effectiveness
Return on assets -0.99%
Return on equity -1.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.7
Total debt (mrq) -
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 11.35%
Book value per share (mrq) 1.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
